# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Renal Cell Carcinoma
- **MONDO ID:**  (if available)
- **Category:** Cancer

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Renal Cell Carcinoma**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** openai
**Generated:** 2026-02-01T10:05:08.856842

1. AnnotationURLCitation(end_index=334, start_index=206, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=RCC%20arises%20from%20epithelial%20cells,13')
2. AnnotationURLCitation(end_index=671, start_index=510, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=The%203%20dominant%20histological%20subtypes,3p%2C%20home%20to%20VHL%2C%20as')
3. AnnotationURLCitation(end_index=1681, start_index=1546, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=hypoxia%20response%20through%20the%20VHL,promoting')
4. AnnotationURLCitation(end_index=1964, start_index=1834, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=%2810,inducible%20factor%20%28HIF%29%20family')
5. AnnotationURLCitation(end_index=2097, start_index=1965, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=sporadic%20disease,of%20ccRCC%20cases%20%5E%7B12')
6. AnnotationURLCitation(end_index=2432, start_index=2272, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=Under%20normal%20oxygen%20tension%2C%20HIF1A,does%20not%20occur%20and%20HIFA')
7. AnnotationURLCitation(end_index=2875, start_index=2740, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=hypoxia%20response%20through%20the%20VHL,promoting')
8. AnnotationURLCitation(end_index=3052, start_index=2876, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=and%20HIF2A%20does%20not%20occur,erythropoietin%2C%20and%20extracellular%20matrix%20proteins')
9. AnnotationURLCitation(end_index=3400, start_index=3269, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=hypoxia%20response%20through%20the%20VHL,VEGFA')
10. AnnotationURLCitation(end_index=3704, start_index=3574, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=%2810,inducible%20factor%20%28HIF%29%20family')
11. AnnotationURLCitation(end_index=3840, start_index=3705, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=hypoxia%20response%20through%20the%20VHL,promoting')
12. AnnotationURLCitation(end_index=4290, start_index=4100, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=Common%20paraneoplastic%20manifestations%20include%20fever,patients%20after%20nephrectomy%20or%20systemic')
13. AnnotationURLCitation(end_index=4550, start_index=4413, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=well%20as%20several%20other%20commonly,21%E2%80%9320')
14. AnnotationURLCitation(end_index=4686, start_index=4551, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=hypoxia%20response%20through%20the%20VHL,promoting')
15. AnnotationURLCitation(end_index=4882, start_index=4780, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=,Google%20Scholar')
16. AnnotationURLCitation(end_index=5187, start_index=5077, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=prevalence%20of%202.3,Box')
17. AnnotationURLCitation(end_index=5612, start_index=5485, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=PBRM,expression%20of%20certain%20genes%20by')
18. AnnotationURLCitation(end_index=5889, start_index=5762, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=PBRM,expression%20of%20certain%20genes%20by')
19. AnnotationURLCitation(end_index=6178, start_index=6046, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L167%20introduction%20of,23%2C%2024')
20. AnnotationURLCitation(end_index=6411, start_index=6274, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L176%20BRCA1,plays%20a%20role%20in%20the')
21. AnnotationURLCitation(end_index=6731, start_index=6594, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L176%20BRCA1,plays%20a%20role%20in%20the')
22. AnnotationURLCitation(end_index=6994, start_index=6877, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=BRCA1,plays%20a%20role%20in%20the')
23. AnnotationURLCitation(end_index=7204, start_index=7068, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=pathogenesis%20of%20ccRCC%20include%20VHL%2C,%5E%7B8')
24. AnnotationURLCitation(end_index=7731, start_index=7610, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=has%20been%20proposed%20%283%20%29,4')
25. AnnotationURLCitation(end_index=8301, start_index=8187, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=pathways.,18%20%E2%80%93%2022')
26. AnnotationURLCitation(end_index=8569, start_index=8435, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=The%20most%20common%20genetic%20alteration,%5E%7B8')
27. AnnotationURLCitation(end_index=8998, start_index=8861, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L176%20BRCA1,plays%20a%20role%20in%20the')
28. AnnotationURLCitation(end_index=9328, start_index=9191, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L176%20BRCA1,plays%20a%20role%20in%20the')
29. AnnotationURLCitation(end_index=10063, start_index=9942, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=has%20been%20proposed%20%283%20%29,4')
30. AnnotationURLCitation(end_index=10450, start_index=10278, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=mTOR%E2%80%93PI3K%20pathway%20starts%20with%20the,lead%20to%20the%20phosphorylation%20of')
31. AnnotationURLCitation(end_index=10577, start_index=10451, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=,cell%20growth%20and%20tumor%20progression')
32. AnnotationURLCitation(end_index=10919, start_index=10773, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L209%20,cell%20growth%20and%20tumor%20progression')
33. AnnotationURLCitation(end_index=11347, start_index=11222, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L221%20Everolimus%20and,line')
34. AnnotationURLCitation(end_index=11873, start_index=11718, title='A Review of Papillary Renal Cell Carcinoma and MET Inhibitors - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6918905/#:~:text=Papillary%20renal%20cell%20carcinoma%20,The%20following%20review%20will')
35. AnnotationURLCitation(end_index=11999, start_index=11874, title='A Review of Papillary Renal Cell Carcinoma and MET Inhibitors - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6918905/#:~:text=PRCC%20is%20further%20subdivided%20into,8')
36. AnnotationURLCitation(end_index=12423, start_index=12298, title='A Review of Papillary Renal Cell Carcinoma and MET Inhibitors - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6918905/#:~:text=PRCC%20is%20further%20subdivided%20into,8')
37. AnnotationURLCitation(end_index=12957, start_index=12780, title='Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4219093/#:~:text=Abstract%20%23%23%23%20Background%20The%20Birt,to%20report%20renal%20tumour%20characteristics')
38. AnnotationURLCitation(end_index=13767, start_index=13591, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=and%20HIF2A%20does%20not%20occur,erythropoietin%2C%20and%20extracellular%20matrix%20proteins')
39. AnnotationURLCitation(end_index=13951, start_index=13768, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=accumulates%20and%20dimerizes%20with%20HIFB,MMP%2C%20matrix%20metalloproteinase%20protein%3B%20mRNA')
40. AnnotationURLCitation(end_index=14325, start_index=14175, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=A%20total%20of%2023%20RCCs,periphery%20and%20the%20tumor%20center')
41. AnnotationURLCitation(end_index=14447, start_index=14326, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=has%20been%20proposed%20%283%20%29,4')
42. AnnotationURLCitation(end_index=14746, start_index=14635, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=The%20glutaminase%20pathway')
43. AnnotationURLCitation(end_index=15067, start_index=14931, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L327%20under%20investigation,42%2C%2043')
44. AnnotationURLCitation(end_index=15616, start_index=15490, title='Fumarate Hydratase Deficiency in Renal Cancer Induces Glycolytic Addiction and Hypoxia-Inducible Transcription Factor 1α Stabilization by Glucose-Dependent Generation of Reactive Oxygen Species - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2715796/#:~:text=and%20Hypoxia,HLRCC%20are%20at%20risk%20to')
45. AnnotationURLCitation(end_index=15765, start_index=15617, title='Fumarate hydratase inactivation in renal tumors: HIF1α, NRF2, and “cryptic targets” of transcription factors - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3777506/#:~:text=Fumarate%20hydratase%20inactivation%20in%20renal,Article%20notes')
46. AnnotationURLCitation(end_index=16205, start_index=16057, title='Fumarate hydratase inactivation in renal tumors: HIF1α, NRF2, and “cryptic targets” of transcription factors - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3777506/#:~:text=Fumarate%20hydratase%20inactivation%20in%20renal,Article%20notes')
47. AnnotationURLCitation(end_index=16377, start_index=16206, title='Fumarate Hydratase Deficiency in Renal Cancer Induces Glycolytic Addiction and Hypoxia-Inducible Transcription Factor 1α Stabilization by Glucose-Dependent Generation of Reactive Oxygen Species - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2715796/#:~:text=in%20several%20model%20systems%2C%20and,following%20experimental%20abrogation%20of%20FH')
48. AnnotationURLCitation(end_index=16852, start_index=16681, title='Fumarate Hydratase Deficiency in Renal Cancer Induces Glycolytic Addiction and Hypoxia-Inducible Transcription Factor 1α Stabilization by Glucose-Dependent Generation of Reactive Oxygen Species - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2715796/#:~:text=in%20several%20model%20systems%2C%20and,following%20experimental%20abrogation%20of%20FH')
49. AnnotationURLCitation(end_index=17176, start_index=17028, title='Fumarate hydratase inactivation in renal tumors: HIF1α, NRF2, and “cryptic targets” of transcription factors - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3777506/#:~:text=Fumarate%20hydratase%20inactivation%20in%20renal,Article%20notes')
50. AnnotationURLCitation(end_index=18081, start_index=17957, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L239%20Under%20normal,These')
51. AnnotationURLCitation(end_index=18225, start_index=18082, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=immune%20response%2C%20leading%20to%20tumor,cell%20receptor')
52. AnnotationURLCitation(end_index=18598, start_index=18461, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=attacking%20and%20eliminating%20cancer,1%29%20pathway')
53. AnnotationURLCitation(end_index=18728, start_index=18599, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=activated%20by%20binding%20PD,immune%E2%80%9D')
54. AnnotationURLCitation(end_index=19165, start_index=19037, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=to%20the%20activation%20of%20cytotoxic,These')
55. AnnotationURLCitation(end_index=19307, start_index=19166, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=of%20PD,available%20are%20nivolumab%20and%20pembrolizumab')
56. AnnotationURLCitation(end_index=19676, start_index=19562, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L247%20,1%2C%2034')
57. AnnotationURLCitation(end_index=19804, start_index=19677, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L564%20,z%20%5BDOI%5D%20%5BPMC')
58. AnnotationURLCitation(end_index=20307, start_index=20142, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=Besides%20genomic%20ITH%2C%20there%20is,tumor%20cell%20proliferation%20in%20this')
59. AnnotationURLCitation(end_index=21590, start_index=21460, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=%2810,inducible%20factor%20%28HIF%29%20family')
60. AnnotationURLCitation(end_index=21726, start_index=21591, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=hypoxia%20response%20through%20the%20VHL,promoting')
61. AnnotationURLCitation(end_index=21996, start_index=21850, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=The%20product%20of%20the%20VHL,the%20VHL%20gene%20product%20is')
62. AnnotationURLCitation(end_index=22389, start_index=22231, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=understanding%20the%20molecular%20basis%20of,of%20ccRCC%20cases%20%5E%7B12')
63. AnnotationURLCitation(end_index=22522, start_index=22390, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=sporadic%20disease,of%20ccRCC%20cases%20%5E%7B12')
64. AnnotationURLCitation(end_index=22746, start_index=22614, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L167%20introduction%20of,23%2C%2024')
65. AnnotationURLCitation(end_index=23205, start_index=23070, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=hypoxia%20response%20through%20the%20VHL,promoting')
66. AnnotationURLCitation(end_index=23694, start_index=23518, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=and%20HIF2A%20does%20not%20occur,erythropoietin%2C%20and%20extracellular%20matrix%20proteins')
67. AnnotationURLCitation(end_index=23878, start_index=23695, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=accumulates%20and%20dimerizes%20with%20HIFB,MMP%2C%20matrix%20metalloproteinase%20protein%3B%20mRNA')
68. AnnotationURLCitation(end_index=24177, start_index=24024, title='Belzutifan for the treatment of renal cell carcinoma - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39926260/#:~:text=Cite%20Display%20options%20,disease%20including%20renal%20cell%20carcinoma')
69. AnnotationURLCitation(end_index=24448, start_index=24178, title='FDA Approves Merck’s WELIREG® (belzutifan) for the Treatment of Patients With Advanced Renal Cell Carcinoma (RCC) Following a PD-1 or PD-L1 Inhibitor and a VEGF-TKI - Merck.com', type='url_citation', url='https://www.merck.com/news/fda-approves-mercks-welireg-belzutifan-for-the-treatment-of-patients-with-advanced-renal-cell-carcinoma-rcc-following-a-pd-1-or-pd-l1-inhibitor-and-a-vegf-tki/#:~:text=The%20approval%20is%20based%20on,6%29%20for%20everolimus')
70. AnnotationURLCitation(end_index=24941, start_index=24670, title='FDA Approves Merck’s WELIREG® (belzutifan) for the Treatment of Patients With Advanced Renal Cell Carcinoma (RCC) Following a PD-1 or PD-L1 Inhibitor and a VEGF-TKI - Merck.com', type='url_citation', url='https://www.merck.com/news/fda-approves-mercks-welireg-belzutifan-for-the-treatment-of-patients-with-advanced-renal-cell-carcinoma-rcc-following-a-pd-1-or-pd-l1-inhibitor-and-a-vegf-tki/#:~:text=%E2%80%9CDespite%20recent%20progress%20in%20the,%E2%80%9D')
71. AnnotationURLCitation(end_index=25428, start_index=25301, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=PBRM,expression%20of%20certain%20genes%20by')
72. AnnotationURLCitation(end_index=25725, start_index=25598, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=PBRM,expression%20of%20certain%20genes%20by')
73. AnnotationURLCitation(end_index=25845, start_index=25726, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=introduction%20of%20PBRM,23%2C%2024')
74. AnnotationURLCitation(end_index=26435, start_index=26298, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L176%20BRCA1,plays%20a%20role%20in%20the')
75. AnnotationURLCitation(end_index=26701, start_index=26564, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L176%20BRCA1,plays%20a%20role%20in%20the')
76. AnnotationURLCitation(end_index=26979, start_index=26842, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L176%20BRCA1,plays%20a%20role%20in%20the')
77. AnnotationURLCitation(end_index=27262, start_index=27145, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=BRCA1,plays%20a%20role%20in%20the')
78. AnnotationURLCitation(end_index=28009, start_index=27844, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=Unexpectedly%2C%20the%20presence%20of%20a,the%20number%20of%20driver%20mutations')
79. AnnotationURLCitation(end_index=28373, start_index=28208, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=Unexpectedly%2C%20the%20presence%20of%20a,the%20number%20of%20driver%20mutations')
80. AnnotationURLCitation(end_index=28829, start_index=28708, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=has%20been%20proposed%20%283%20%29,4')
81. AnnotationURLCitation(end_index=29364, start_index=29230, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=tumor%20cells,did%20not%20harbor%20mTOR%20pathway')
82. AnnotationURLCitation(end_index=29535, start_index=29365, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=stratification%20%2812%20%29,translates%20into%20corresponding%20downstream%20effects')
83. AnnotationURLCitation(end_index=30240, start_index=30085, title='A Review of Papillary Renal Cell Carcinoma and MET Inhibitors - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6918905/#:~:text=Papillary%20renal%20cell%20carcinoma%20,The%20following%20review%20will')
84. AnnotationURLCitation(end_index=30366, start_index=30241, title='A Review of Papillary Renal Cell Carcinoma and MET Inhibitors - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6918905/#:~:text=PRCC%20is%20further%20subdivided%20into,8')
85. AnnotationURLCitation(end_index=31077, start_index=30952, title='A Review of Papillary Renal Cell Carcinoma and MET Inhibitors - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6918905/#:~:text=PRCC%20is%20further%20subdivided%20into,8')
86. AnnotationURLCitation(end_index=31618, start_index=31441, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=hereditary%20renal%20cancer%20syndromes%20exist,genetic%20counseling%20of%20family%20members')
87. AnnotationURLCitation(end_index=31902, start_index=31776, title='Fumarate Hydratase Deficiency in Renal Cancer Induces Glycolytic Addiction and Hypoxia-Inducible Transcription Factor 1α Stabilization by Glucose-Dependent Generation of Reactive Oxygen Species - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2715796/#:~:text=and%20Hypoxia,HLRCC%20are%20at%20risk%20to')
88. AnnotationURLCitation(end_index=32051, start_index=31903, title='Fumarate hydratase inactivation in renal tumors: HIF1α, NRF2, and “cryptic targets” of transcription factors - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3777506/#:~:text=Fumarate%20hydratase%20inactivation%20in%20renal,Article%20notes')
89. AnnotationURLCitation(end_index=32475, start_index=32354, title='A Review of Papillary Renal Cell Carcinoma and MET Inhibitors - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6918905/#:~:text=characteristic%20common%20mutations,8')
90. AnnotationURLCitation(end_index=32917, start_index=32746, title='Fumarate Hydratase Deficiency in Renal Cancer Induces Glycolytic Addiction and Hypoxia-Inducible Transcription Factor 1α Stabilization by Glucose-Dependent Generation of Reactive Oxygen Species - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2715796/#:~:text=in%20several%20model%20systems%2C%20and,following%20experimental%20abrogation%20of%20FH')
91. AnnotationURLCitation(end_index=34048, start_index=33917, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=hypoxia%20response%20through%20the%20VHL,VEGFA')
92. AnnotationURLCitation(end_index=34562, start_index=34403, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=that%20impair%20angiogenesis%20and%20block,and%20programmed%20cell%20death')
93. AnnotationURLCitation(end_index=34681, start_index=34563, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=sunitinib%2C%20tivozanib%20%20,IV')
94. AnnotationURLCitation(end_index=36451, start_index=36301, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=Renal%20cell%20carcinoma%20,in%20a%20spatially%20defined%20manner')
95. AnnotationURLCitation(end_index=36573, start_index=36452, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=has%20been%20proposed%20%283%20%29,4')
96. AnnotationURLCitation(end_index=37204, start_index=37062, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=A%20%E2%80%9Ctwo,takes%20place%20via%20somatic%20mutations')
97. AnnotationURLCitation(end_index=37416, start_index=37284, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=sporadic%20disease,of%20ccRCC%20cases%20%5E%7B12')
98. AnnotationURLCitation(end_index=37738, start_index=37596, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=A%20%E2%80%9Ctwo,takes%20place%20via%20somatic%20mutations')
99. AnnotationURLCitation(end_index=38816, start_index=38695, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=has%20been%20proposed%20%283%20%29,4')
100. AnnotationURLCitation(end_index=39245, start_index=39108, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L176%20BRCA1,plays%20a%20role%20in%20the')
101. AnnotationURLCitation(end_index=39518, start_index=39381, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L176%20BRCA1,plays%20a%20role%20in%20the')
102. AnnotationURLCitation(end_index=39804, start_index=39679, title='A Review of Papillary Renal Cell Carcinoma and MET Inhibitors - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6918905/#:~:text=PRCC%20is%20further%20subdivided%20into,8')
103. AnnotationURLCitation(end_index=41416, start_index=41294, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=Metastatic%20disease%20,40%20%2C%2047')
104. AnnotationURLCitation(end_index=41989, start_index=41904, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=')
105. AnnotationURLCitation(end_index=42629, start_index=42486, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=immune%20response%2C%20leading%20to%20tumor,cell%20receptor')
106. AnnotationURLCitation(end_index=43164, start_index=42999, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=Besides%20genomic%20ITH%2C%20there%20is,tumor%20cell%20proliferation%20in%20this')
107. AnnotationURLCitation(end_index=43397, start_index=43258, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=includes%20the%20formation%20of%20intratumoral,genetic')
108. AnnotationURLCitation(end_index=43841, start_index=43676, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=Unexpectedly%2C%20the%20presence%20of%20a,the%20number%20of%20driver%20mutations')
109. AnnotationURLCitation(end_index=43991, start_index=43842, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=In%20the%20present%20proof,and%20precision%20medicine%20in%20RCC')
110. AnnotationURLCitation(end_index=45987, start_index=45824, title='Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/29656891/#:~:text=Clear%20cell%20renal%20cell%20carcinoma,differences%20in%20age%20incidence%20between')
111. AnnotationURLCitation(end_index=46171, start_index=45988, title='Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/29656891/#:~:text=most%20common%20structural%20abnormality%20generates,offering%20opportunity%20for%20early%20intervention')
112. AnnotationURLCitation(end_index=46782, start_index=46642, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=How%20Are%20Most%20Renal%20Cell,Carcinomas%20Identified')
113. AnnotationURLCitation(end_index=47093, start_index=46953, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=How%20Are%20Most%20Renal%20Cell,Carcinomas%20Identified')
114. AnnotationURLCitation(end_index=47424, start_index=47288, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=Between%2037,more%20often%20in%20advanced%20disease')
115. AnnotationURLCitation(end_index=48047, start_index=47911, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=Between%2037,more%20often%20in%20advanced%20disease')
116. AnnotationURLCitation(end_index=48172, start_index=48048, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=onset%2C%20only%20large%20RCCs%20are,24')
117. AnnotationURLCitation(end_index=48503, start_index=48321, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=Paraneoplastic%20syndromes%20occur%20in%2010,with%20RCC%3B%20hepatosplenomegaly%20without%20liver')
118. AnnotationURLCitation(end_index=48917, start_index=48730, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=Common%20paraneoplastic%20manifestations%20include%20fever,Stauffer%20syndrome%2C%20a%20paraneoplastic')
119. AnnotationURLCitation(end_index=49220, start_index=49033, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=Common%20paraneoplastic%20manifestations%20include%20fever,Stauffer%20syndrome%2C%20a%20paraneoplastic')
120. AnnotationURLCitation(end_index=49721, start_index=49539, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=Paraneoplastic%20syndromes%20occur%20in%2010,with%20RCC%3B%20hepatosplenomegaly%20without%20liver')
121. AnnotationURLCitation(end_index=50372, start_index=50218, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=hypertension%20%283,nephrectomy%20may%20indicate%20residual%20disease')
122. AnnotationURLCitation(end_index=50796, start_index=50627, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=cells%20upon%20VHL%20inactivation.,nephrectomy%20may%20indicate%20residual%20disease')
123. AnnotationURLCitation(end_index=51099, start_index=50917, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=Paraneoplastic%20syndromes%20occur%20in%2010,with%20RCC%3B%20hepatosplenomegaly%20without%20liver')
124. AnnotationURLCitation(end_index=51774, start_index=51592, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=Paraneoplastic%20syndromes%20occur%20in%2010,with%20RCC%3B%20hepatosplenomegaly%20without%20liver')
125. AnnotationURLCitation(end_index=52229, start_index=52047, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=Paraneoplastic%20syndromes%20occur%20in%2010,with%20RCC%3B%20hepatosplenomegaly%20without%20liver')
126. AnnotationURLCitation(end_index=52708, start_index=52521, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=Common%20paraneoplastic%20manifestations%20include%20fever,Stauffer%20syndrome%2C%20a%20paraneoplastic')
127. AnnotationURLCitation(end_index=53203, start_index=53038, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=match%20at%20L613%20Patients%20treated,77%E2%80%9379%7D%20Table%202%20summarizes')
128. AnnotationURLCitation(end_index=54674, start_index=54546, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=RCC%20arises%20from%20epithelial%20cells,13')
129. AnnotationURLCitation(end_index=56865, start_index=56736, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=,0642%20%5BDOI%5D%20%5BPubMed%5D%20%5BGoogle')
130. AnnotationURLCitation(end_index=57467, start_index=57353, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L247%20,1%2C%2034')
131. AnnotationURLCitation(end_index=57605, start_index=57468, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L176%20BRCA1,plays%20a%20role%20in%20the')
132. AnnotationURLCitation(end_index=58884, start_index=58715, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=cells%20upon%20VHL%20inactivation.,nephrectomy%20may%20indicate%20residual%20disease')
133. AnnotationURLCitation(end_index=59343, start_index=59214, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=into%20papillary%20RCC%20and%20classified,14')
134. AnnotationURLCitation(end_index=59832, start_index=59674, title='Molecular Pathways: Fumarate Hydratase-Deficient Kidney Cancer: Targeting the Warburg Effect in Cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4447120/#:~:text=the%20Warburg%20Effect%20in%20Cancer,Fumarate%20hydratase%3A%20the%20HLRCC')
135. AnnotationURLCitation(end_index=60400, start_index=60130, title='FDA Approves Merck’s WELIREG® (belzutifan) for the Treatment of Patients With Advanced Renal Cell Carcinoma (RCC) Following a PD-1 or PD-L1 Inhibitor and a VEGF-TKI - Merck.com', type='url_citation', url='https://www.merck.com/news/fda-approves-mercks-welireg-belzutifan-for-the-treatment-of-patients-with-advanced-renal-cell-carcinoma-rcc-following-a-pd-1-or-pd-l1-inhibitor-and-a-vegf-tki/#:~:text=The%20approval%20is%20based%20on,6%29%20for%20everolimus')
136. AnnotationURLCitation(end_index=61080, start_index=60911, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L356%20In%20addition%2C,cabozantinib%20in%20separate%20clinical%20trials')
137. AnnotationURLCitation(end_index=61262, start_index=61081, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=In%20addition%2C%20the%20glutaminase%20inhibitor,cabozantinib%20in%20separate%20clinical%20trials')
138. AnnotationURLCitation(end_index=61776, start_index=61618, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=%5BPubMed%5D%20%5BGoogle%20Scholar%5D%20,C%2C%20Hermanns%20T%2C%20et%20al')
139. AnnotationURLCitation(end_index=62667, start_index=62484, title='Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/29656891/#:~:text=most%20common%20structural%20abnormality%20generates,offering%20opportunity%20for%20early%20intervention')
140. AnnotationURLCitation(end_index=62841, start_index=62668, title='Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/29656891/#:~:text=or%20adolescence%2C%20generally%20as%20the,offering%20opportunity%20for%20early%20intervention')
141. AnnotationURLCitation(end_index=63153, start_index=63016, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L176%20BRCA1,plays%20a%20role%20in%20the')
142. AnnotationURLCitation(end_index=63571, start_index=63422, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=In%20the%20present%20proof,and%20precision%20medicine%20in%20RCC')
143. AnnotationURLCitation(end_index=63841, start_index=63752, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=,doi')
144. AnnotationURLCitation(end_index=64206, start_index=64113, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=Urol,doi')
145. AnnotationURLCitation(end_index=64602, start_index=64429, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=The%20therapeutic%20landscape%20of%20RCC,advances%2C%20a%20substantial%20proportion%20of')
146. AnnotationURLCitation(end_index=64779, start_index=64603, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=and%20the%20current%20standard%20of,ultimately%20experience%20malignant%20progression%20and')
147. AnnotationURLCitation(end_index=65363, start_index=65200, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=worldwide%2C%20with%20more%20than%20179,due%20to%20improvements%20in%20therapy')
148. AnnotationURLCitation(end_index=65612, start_index=65496, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=Renal%20cell%20carcinoma%20,Box')
149. AnnotationURLCitation(end_index=65864, start_index=65754, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=Stage%20%20,27%E2%80%9328')
150. AnnotationURLCitation(end_index=66240, start_index=66069, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=Systemic%20treatment%20is%20effective%20in,patients%20with%20RCC%20after%20nephrectomy')
151. AnnotationURLCitation(end_index=67337, start_index=67227, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=prevalence%20of%202.3,Box')
152. AnnotationURLCitation(end_index=67893, start_index=67732, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=The%203%20dominant%20histological%20subtypes,3p%2C%20home%20to%20VHL%2C%20as')
153. AnnotationURLCitation(end_index=68029, start_index=67894, title='Renal Cell Carcinoma - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11790279/#:~:text=hypoxia%20response%20through%20the%20VHL,promoting')
154. AnnotationURLCitation(end_index=68361, start_index=68238, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=Multiple%20risk%20factors%20for%20RCC,7')
155. AnnotationURLCitation(end_index=68496, start_index=68362, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=The%20most%20common%20genetic%20alteration,%5E%7B8')
156. AnnotationURLCitation(end_index=68873, start_index=68710, title='Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/29656891/#:~:text=Clear%20cell%20renal%20cell%20carcinoma,differences%20in%20age%20incidence%20between')
157. AnnotationURLCitation(end_index=69289, start_index=69164, title='A Review of Papillary Renal Cell Carcinoma and MET Inhibitors - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6918905/#:~:text=PRCC%20is%20further%20subdivided%20into,8')
158. AnnotationURLCitation(end_index=69716, start_index=69545, title='Fumarate Hydratase Deficiency in Renal Cancer Induces Glycolytic Addiction and Hypoxia-Inducible Transcription Factor 1α Stabilization by Glucose-Dependent Generation of Reactive Oxygen Species - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2715796/#:~:text=in%20several%20model%20systems%2C%20and,following%20experimental%20abrogation%20of%20FH')
159. AnnotationURLCitation(end_index=70218, start_index=69948, title='FDA Approves Merck’s WELIREG® (belzutifan) for the Treatment of Patients With Advanced Renal Cell Carcinoma (RCC) Following a PD-1 or PD-L1 Inhibitor and a VEGF-TKI - Merck.com', type='url_citation', url='https://www.merck.com/news/fda-approves-mercks-welireg-belzutifan-for-the-treatment-of-patients-with-advanced-renal-cell-carcinoma-rcc-following-a-pd-1-or-pd-l1-inhibitor-and-a-vegf-tki/#:~:text=The%20approval%20is%20based%20on,6%29%20for%20everolimus')
160. AnnotationURLCitation(end_index=70490, start_index=70219, title='FDA Approves Merck’s WELIREG® (belzutifan) for the Treatment of Patients With Advanced Renal Cell Carcinoma (RCC) Following a PD-1 or PD-L1 Inhibitor and a VEGF-TKI - Merck.com', type='url_citation', url='https://www.merck.com/news/fda-approves-mercks-welireg-belzutifan-for-the-treatment-of-patients-with-advanced-renal-cell-carcinoma-rcc-following-a-pd-1-or-pd-l1-inhibitor-and-a-vegf-tki/#:~:text=%E2%80%9CDespite%20recent%20progress%20in%20the,%E2%80%9D')
161. AnnotationURLCitation(end_index=70838, start_index=70736, title='Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12061699/#:~:text=,Google%20Scholar')
162. AnnotationURLCitation(end_index=71172, start_index=71058, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L247%20,1%2C%2034')
163. AnnotationURLCitation(end_index=71300, start_index=71173, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L564%20,z%20%5BDOI%5D%20%5BPMC')
164. AnnotationURLCitation(end_index=71609, start_index=71490, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=introduction%20of%20PBRM,23%2C%2024')
165. AnnotationURLCitation(end_index=71747, start_index=71610, title='Renal cell carcinoma: a review of biology and pathophysiology - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5850086/#:~:text=match%20at%20L176%20BRCA1,plays%20a%20role%20in%20the')